de Boer, S. A., Reijrink, M., Abdulahad, W. H., Hoekstra, E. S., Slart, R. H. J. A., Heerspink, H. J. L., . . . Mulder, D. J. (2020). Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study). Diabetes Obes Metab.

de Boer, Stefanie A., Melanie Reijrink, Wayel H. Abdulahad, Elisa S. Hoekstra, Riemer H. J. A. Slart, Hiddo J. L. Heerspink, Johanna Westra, and Douwe J. Mulder. "Angiogenic T Cells Are Decreased in People With Type 2 Diabetes Mellitus and Recruited By the Dipeptidyl Peptidase‐4 Inhibitor Linagliptin: A Subanalysis From a Randomized, Placebo‐controlled Trial (RELEASE Study)." Diabetes Obes Metab 2020.

de Boer, Stefanie A., et al. "Angiogenic T Cells Are Decreased in People With Type 2 Diabetes Mellitus and Recruited By the Dipeptidyl Peptidase‐4 Inhibitor Linagliptin: A Subanalysis From a Randomized, Placebo‐controlled Trial (RELEASE Study)." Diabetes Obes Metab 2020.